Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Niraparib with abiraterone acetate and prednisone for metastatic castration resistant prostate cancer	Abiraterone acetate (Zytiga; Yonsa) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) , Prednisone (Decadron; Lodotra)	Prostate cancer	Male Reproductive Cancer	2022	View \| Download
Nintedanib for treating interstitial lung disease in children aged 6 to 17 years old	Nintedanib (Vargatef; Ofev; nintedanib esilate)	Interstitial lung disease (ILD)	Dermatology , Respiratory System	2022	View \| Download
Nicardipine for treating aneurysmal subarachnoid haemorrhage	Nicardipine (NicaPlant; nicardipine hydrochloride)	Aneurysmal subarachnoid haemorrhage	Cardiovascular System	2022	View \| Download
Neoadjuvant atezolizumab with chemotherapy followed by adjuvant atezolizumab for treating triple-negative breast cancer	Atezolizumab (Tecentriq; MPDL3280A) , Chemotherapy	Breast cancer	Breast Cancer	2022	View \| Download
Nemolizumab for treating atopic dermatitis and prurigo nodularis	Nemolizumab	Atopic dermatitis , Prurigo nodularis (PN)	Dermatology	2022	View \| Download
Nedosiran for primary hyperoxaluria	Nedosiran (DCR-PHXC)	Primary hyperoxaluria	Nephrology	2022	View \| Download
Navitoclax with ruxolitinib for myelofibrosis	Navitoclax (ABT 263, ABT-263) , Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate)	Myelofibrosis	Haematological Cancer and Lymphomas	2022	View \| Download
Natalizumab biosimilar for treating relapsing-remitting multiple sclerosis	Natalizumab biosimilar (PB006)	Multiple sclerosis (MS)	Neurology	2022	View \| Download
Momelotinib for the treatment of symptomatic and anaemic myelofibrosis	Momelotinib	Anaemic myelofibrosis	Haematological Cancer and Lymphomas , Haematology	2022	View \| Download
Mirikizumab for treating moderately to severely active Crohn’s disease	Mirikizumab (LY3074828)	Crohn's disease	Gastroenterology , Immunology	2022	View \| Download